An Evaluation of the Cost-Effectiveness of Reslizumab in Poorly Controlled Eosinophilic Asthma
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1592
https://www.valueinhealthjournal.com/article/S1098-3015(18)31898-9/fulltext
Title :
An Evaluation of the Cost-Effectiveness of Reslizumab in Poorly Controlled Eosinophilic Asthma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31898-9&doi=10.1016/j.jval.2018.04.1592
First page :
Section Title :
Open access? :
No
Section Order :
825